Clinical trial Recruiting at 1 site Observational Ages 18 and up

Impact of environmental exposures on tumor risk in SDHx mutation carriers

Official title: Impact of Environmental Exposures on Tumor Risk in Subjects at Risk of Hereditary SDHx-related Paragangliomas - National Study

Run by Assistance Publique - Hôpitaux de Paris · NCT06408402 · Data updated 2026-11-12

This study tests whether exposure to SDHi chemicals from work, home, or the environment affects tumor development in people with SDHx gene mutations.

More Environmental Exposure trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment1300 (estimated)
SponsorAssistance Publique - Hôpitaux de Paris
Academic / other
Locations20 sites (Angers and 19 other locations)
StatusRecruiting
StartedMay 22, 2024
Main results expectedMay 22, 2028
Study endsMay 22, 2028
Registry record updatedJuly 9, 2026
Trial IDNCT06408402 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

SDHx mutation carriers who have or have not developed an SDHx-related tumor, willing to complete questionnaires and provide a blood sample.

Probably not a fit

Individuals without SDHx mutations or without exposure to SDHi risks may have little personal benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study compares SDHx mutation carriers who have developed SDHx-related tumors with those who have not. Past environmental and occupational exposures are collected via a telephone questionnaire, and a blood sample is offered. Cases and controls are matched by age and affected gene to explore the link between SDHi exposure and tumor risk. The lead sponsor is AP-HP, with collaboration from INSA, ANSES, and Centre Leon Berard, across several French centers.

Why it matters

Potential benefit: If associations are found, this could inform risk reduction and monitoring strategies for SDHx mutation carriers.

How similar studies have gone: Other studies have explored environmental factors in SDHx-related tumors, but definitive links remain to be established; this study adds targeted exposure data.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Cases: SDHx mutation carriers diagnosed for a SDHx-related tumor
* Controls: SDHx mutation carriers with no SDHx-related tumor

Exclusion Criteria:

* Incapacity to exercise free and informed consent for the study
* Patient under tutorship or guardianship or legal safeguard

Where it's running

  • Hôpital européen Georges Pompidou - APHP
    Paris, France
    Recruiting
  • CHU d'Angers
    Angers, France
    Active not recruiting
  • CHU Jean Minjoz Besançon
    Besançon, France
    Active not recruiting
  • Hôpital Louis Pradel
    Bron, France
    Active not recruiting
  • CHU de Caen
    Caen, France
    Active not recruiting
  • Hôpital Michalon - CHU Grenoble
    Grenoble, France
    Active not recruiting
Show 14 more locations
  • CHU de Lille - Hôpital HURIEZ
    Lille, France
    Active not recruiting
  • Hopital de la Conception - Marseille
    Marseille, France
    Active not recruiting
  • CHU de Montpellier - Hôpital Lapeyronie
    Montpellier, France
    Active not recruiting
  • CHU de Nantes
    Nantes, France
    Active not recruiting
  • CHU de Nice -Hôpital Archet 2
    Nice, France
    Active not recruiting
  • Hôpital Pitié-Salpêtrière - APHP
    Paris, France
    Active not recruiting
  • Hôpital Cochin - APHP
    Paris, France
    Active not recruiting
  • Hôpital européen Georges Pompidou - APHP
    Paris, France
    Active not recruiting
  • CHU de Poitiers
    Poitiers, France
    Active not recruiting
  • CHU de Rennes - Hôpital Sud
    Rennes, France
    Active not recruiting
  • Hôpitaux universitaire de Strasbourg - Hôpital de Hautepierre
    Strasbourg, France
    Active not recruiting
  • CHU de Toulouse - Hôpita Larrey
    Toulouse, France
    Active not recruiting
  • CHU Bretonneau
    Tours, France
    Active not recruiting
  • Institut Gustave Roussy
    Villejuif, France
    Active not recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.